Xeljanz is a medication that is linked to an increased risk of heart attacks, strokes, cancer, blood clots and death.
What You Can Do & How We Can Help
The Schmidt Firm, PLLC is currently accepting Xeljanz induced injury cases in all 50 states. If you or somebody you know has been diagnosed with cancer, a heart attack, stroke, blood clots, or death after taking Xeljanz, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
UPDATE: FDA Orders “Black Box” Warnings for Xeljanz
In September 2021, the FDA ordered Pfizer to add a “Black Box” warning label on Xeljanz about an increased risk of the following severe, life-threatening side effects:
- Heart attacks
- Cancer (particularly lymphoma and lung cancer)
- Blood clots
New Warnings Added for Blood Clot & Death Risk
In July 2019, the FDA added a Boxed Warning label on Xeljanz about an increased risk of blood clots and death with the 10-mg twice-daily dose of Xeljanz and Xeljanz XR (tofacitinib).
Patients should stop taking Xeljanz and seek emergency medical attention right away if you experience any unusual symptoms, including symptoms of a blood clot, such as:
- Sudden shortness of breath
- Chest pain that worsens with breathing
- Swelling of a leg or arm
- Leg pain or tenderness, or red or discolored skin in the painful or swollen leg or arm
Xeljanz Linked to Higher Risk of Blood Clots, Pulmonary Embolism, Death
In February 2019, the FDA issued a warning about an increased risk of blood clots in the lungs (pulmonary embolism) and death in patients with rheumatoid arthritis who were prescribed twice-daily 10-mg doses.
High Dose of Xeljanz is Not Approved for Arthritis
The FDA has not approved this twice-daily 10-mg dose for rheumatoid arthritis. It is only approved for the treatment of ulcerative colitis. The FDA urges doctors to follow the recommendations in the prescribing guidelines for the specific disease they are treating.
Symptoms of a Pulmonary Embolism
Patients should not stop taking Xeljanz without first consulting a doctor because doing so could worsen their condition. Patients taking Xeljanz should seek emergency medical attention if they develop symptoms of a blood clot in the lungs, such as:
- Sudden shortness of breath or difficulty breathing
- Chest pain or pain in your back
- Coughing up blood
- Excessive sweating
- Clammy or bluish colored skin
What is Xeljanz?
Xeljanz® and Xeljanz XR® (generic: tofacitinib) are medications that are sold by Pfizer for the treatment of diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. These diseases occur when the body is attacked by its own over-active immune system. Xeljanz works by decreasing the activity of the immune system.
Can I Join a Class Action Lawsuit?
The Schmidt Firm, PLLC is nationally recognized as a class action law firm, but we are not currently filing a Xeljanz class action. Instead, we are investigating individual lawsuits for people who were diagnosed with severe side effects.
About Class Actions
Class actions are useful when a lot of people have a relatively similar legal claim, such as a refund after buying a product that was falsely advertised. However, class actions can have disadvantages for individuals with very serious injuries, particularly when those individuals are far more seriously injured than the average person who used a defective medication.
Why Our Law Firm is Filing Individual Lawsuits as Opposed to a Class Action
If you or your family member were injured by Xeljanz, you may qualify to file a lawsuit against Pfizer. Our lawyers may be able to help you file a lawsuit, seek justice and compensation for your pain and suffering, medical expenses, lost income, long-term injuries, or the wrongful death of a loved one.
Do I have a Xeljanz Lawsuit?
The Schmidt Firm, PLLC is currently accepting Xeljanz induced injury cases in all 50 states. If you or somebody you know has been diagnosed with cancer, a major cardiovascular event, blood clots, or death after taking Xeljanz, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.